← Open Payments lookup

MADELINE EL-GHOUL: Open Payments

NPI 1437718699 · IJAMSVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,141 in 55 payments from 14 companies in 2025. Trend: 2023 $2,281 · 2024 $2,369 · 2025 $1,141

Food & beverage: $1,141
CompanyPaymentsAmount
ABBVIE INC.11$210
AstraZeneca Pharmaceuticals LP10$199
Lilly USA, LLC6$134
Novo Nordisk Inc5$117
GlaxoSmithKline, LLC.5$113
PFIZER INC.4$87
Amgen Inc.3$63
Astellas Pharma US Inc2$49
Boehringer Ingelheim Pharmaceuticals, Inc.2$41
Xeris Pharmaceuticals, Inc.2$38

Products named: AIRSUPRA, QULIPTA, MOUNJARO, Ozempic, TRELEGY ELLIPTA, UBRELVY, NURTEC ODT, Veozah.

Industry payments across MD — which companies pay providers there.